Thalomid and Gallbladder disorder - a phase IV clinical study of FDA data

Summary:

Gallbladder disorder is reported as a side effect among people who take Thalomid (thalidomide), especially for people who are male, 60+ old, have been taking the drug for 1 - 2 years also take Revlimid, and have Behcet's syndrome.

The phase IV clinical study analyzes which people have Gallbladder disorder when taking Thalomid. It is created by eHealthMe based on reports of 38,055 people who have side effects when taking Thalomid from the FDA, and is updated regularly.

What is Thalomid?

Thalomid has active ingredients of thalidomide. It is often used in multiple myeloma. eHealthMe is studying from 38,099 Thalomid users. Check the latest studies of Thalomid.

What is Gallbladder disorder?

Gallbladder disorder is found to be associated with 1,194 drugs and 1,784 conditions by eHealthMe. Check the latest studies of Gallbladder disorder.

On Aug, 10, 2026

38,055 people reported to have side effects when taking Thalomid.
Among them, 25 people (0.07%) have Gallbladder disorder.

Could Thalomid cause Gallbladder disorder?

Among these 25 people:

How long have people been on Thalomid when they have Gallbladder disorder? *

What is the gender of people who have Gallbladder disorder when taking Thalomid? *

female: 40 %
male: 60 %

What is the age of people who have Gallbladder disorder when taking Thalomid? *

What are other drugs people take besides Thalomid? *

What are other side effects people have besides Gallbladder disorder? *

Pneumonia: 4 people, 16.00%
Dehydration (dryness resulting from the removal of water): 3 people, 12.00%
High Blood Pressure: 3 people, 12.00%
Fever: 3 people, 12.00%
Hypoaesthesia (reduced sense of touch or sensation): 3 people, 12.00%
Cholecystitis (infection of gallbladder): 2 people, 8.00%
Weakness: 2 people, 8.00%
Itching: 2 people, 8.00%
Malaise (a feeling of general discomfort or uneasiness): 2 people, 8.00%
Gastrointestinal Haemorrhage (bleeding gastrointestinal tract): 2 people, 8.00%

What are the existing conditions these people have? *

Behcet's Syndrome (involves inflammation of the blood vessels): 4 people, 16.00%
Systemic Lupus Erythematosus (an autoimmune disease, which means the body's immune system mistakenly, attacks healthy tissue): 1 person, 4.00%
Oesophageal Carcinoma (cancer tumour of oesophagus): 1 person, 4.00%
Malignant Melanoma (skin cancer rises from melancytes): 1 person, 4.00%
Colorectal Cancer Metastatic (cancer of colon and rectal spreads to other parts): 1 person, 4.00%

* Approximation only. Some reports may have incomplete information.

Do you take Thalomid and have Gallbladder disorder?

- Check whether Gallbladder disorder is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Thalomid:

Thalomid (38,099 reports)

Browse all side effects of Thalomid:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Gallbladder disorder:

Gallbladder disorder (1,194 drugs)

Browse all the conditions that are associated with Gallbladder disorder:

Gallbladder disorder (1,784 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on thalidomide (the active ingredients of Thalomid) and Thalomid (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.